Thomas Stankovich's Net Worth
-$302 Thousand
Who is Thomas Stankovich?
Thomas Stankovich does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ReShape Lifesciences Inc., Cobalis Corp, ReShape Lifesciences Inc., and RESPONSE GENETICS INC.
SEC CIK
Thomas Stankovich's CIK is 0001181166
Past Insider Trading and Trends
2009 was Thomas Stankovich's most active year for acquiring shares with 10 total transactions. Thomas Stankovich's most active month to acquire stocks was the month of November. 2022 was Thomas Stankovich's most active year for disposing of shares, totalling 16 transactions. Thomas Stankovich's most active month to dispose stocks was the month of October. 2006 saw Thomas Stankovich paying a total of $1,919,166.50 for 1,178,070 shares, this is the most they've acquired in one year. In 2006 Thomas Stankovich cashed out on 1,000,000 shares for a total of $1,750,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ReShape Lifesciences Inc. No price found
Chief Financial OfficerThomas Stankovich owns 4,635 units of Common Stock. Thomas Stankovich used to own units in Common Stock, $0.001 par value per share but no longer holds any shares there.acquired a total of 4,635 shares in ReShape Lifesciences Inc. at a cost of $13,905.00, Thomas also disposed a total of 4,635 shares of ReShape Lifesciences Inc. equalling to $14,136.75.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.63K |
$3.05 | -$14,136.75 |
0
|
Jun 15
| |||
Form 4
| +12.91% | 530 |
$3.00 | $1,590.00 | 4.63K |
Sep 16
| |||
Form 4
|
∞
| 4.11K |
$3.00 | $12,315.00 | 4.11K |
Aug 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cobalis Corp No price found
Chief Financial OfficerThomas Stankovich owns 428,070 units of Common stock.acquired a total of 328,070 shares in Cobalis Corp at a cost of $386,666.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
| +71.23% | 178.07K |
$0.95 | $169,166.50 | 428.07K |
Nov 1
| |||
Form 4
| +150.00% | 150K |
$1.45 | $217,500.00 | 250K |
Jan 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ReShape Lifesciences Inc. (RSLS) Snapshot price: $0.1471
Chief Financial OfficerThomas Stankovich owns 22,777 units of Common Stock, $0.001 par value per share which is worth $3,350.50. From 2021 to 2024 Thomas Stankovich acquired a total of 825,202 shares in ReShape Lifesciences Inc. at a cost of $185,449.36, Thomas also disposed a total of 489,627 shares of ReShape Lifesciences Inc. equalling to $276,099.91.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.75% | -172.00 |
$0.23 | -$38.78 | 22.78K |
Nov 30 - May 31
| |||
Form 4
| -1.86% | -435.00 |
$0.89 | -$386.48 | 22.95K |
Aug 4 - Oct 25
| |||
Form 4
| -0.45% | -106.00 |
$1.47 | -$155.82 | 23.38K |
Jul 6
| |||
Form 4
| +285.65% | 17.4K |
$1.99 | $26,160.90 | 23.49K |
Mar 31 - Jun 30
| |||
Form 4
| -6.42% | -418.00 |
$8.87 | -$3,707.77 | 6.09K |
Jan 24 - Feb 28
| |||
Form 4
| -2.21% | -7.36K |
$0.17 | -$62,938.37 | 325.4K |
Nov 17 - Dec 1
| |||
Form 4
| -2.46% | -8.39K |
$0.27 | -$2,286.84 | 332.76K |
Nov 4
| |||
Form 4
| -2.39% | -8.29K |
$0.28 | -$2,329.09 | 338.67K |
Oct 4
| |||
Form 4
| -1.37% | -4.83K |
$0.39 | -$1,882.92 | 346.96K |
Sep 6
| |||
Form 4
| -1.33% | -4.73K |
$0.47 | -$2,222.16 | 351.79K |
Aug 5
| |||
Form 4
| -1.28% | -4.63K |
$0.55 | -$2,546.50 | 356.52K |
Jul 1
| |||
Form 4
| -1.22% | -4.48K |
$0.96 | -$4,298.88 | 361.15K |
Jun 1
| |||
Form 4
| +5.79% | 20K |
$0.92 | $18,422.32 | 365.63K |
May 31
| |||
Form 4
| -1.29% | -4.53K |
$0.77 | -$3,487.33 | 345.63K |
May 5
| |||
Form 4
| -1.42% | -5.04K |
$1.13 | -$5,692.94 | 350.16K |
Apr 1
| |||
Form 4
| -1.02% | -3.66K |
$1.06 | -$3,877.48 | 355.19K |
Feb 28
| |||
Form 4
| -1.02% | -3.68K |
$1.22 | -$4,494.48 | 358.85K |
Jan 31
| |||
Form 4
| -0.87% | -3.17K |
$1.78 | -$5,644.38 | 362.54K |
Jan 4
| |||
Form 4
| -1.16% | -4.30K |
$1.83 | -$7,863.41 | 365.71K |
Dec 2
| |||
Form 4
| +5.71% | 20K |
$2.02 | $40,400.00 | 370.01K |
Nov 18
| |||
Form 4
| -1.22% | -4.32K |
$2.69 | -$11,620.80 | 350.01K |
Nov 2
| |||
Form 4
| -1.02% | -3.66K |
$2.76 | -$10,101.60 | 354.33K |
Oct 1
| |||
Form 4
| +965.04% | 324.38K |
$2.89 | -$139,777.74 | 357.99K |
Jul 22 - Sep 10
| |||
Form 4
| +85.16% | 15K |
$3.43 | $51,435.00 | 32.61K |
Aug 30
| |||
Form 4
| +574.05% | 15K |
$3.22 | $48,285.00 | 17.61K |
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RESPONSE GENETICS INC No price found
Former Vice President & CFOThomas Stankovich owns 67,488 units of Common Stock. From 2007 to 2010 Thomas Stankovich acquired a total of 7,000 shares in RESPONSE GENETICS INC at a cost of $9,450.95.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17 - Jun 16
| |||
Form 4
| +11.57% | 7K |
$1.35 | $9,450.95 | 67.49K |
Dec 10 - Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||